Implementing the WHO Resolution on Chronic Kidney Disease

A Health Policy paper published June 13, 2026, in The Lancet urges global health authorities to integrate chronic kidney disease (CKD) into the broader non-communicable disease (NCD) agenda. The guidance aims to operationalize a November 2025 World Health Organization (WHO) resolution on kidney health by adopting strategies used in diabetes control to overcome institutional inertia and indifference.

The Lancet paper identifies a gap between the adoption of international health agreements and their actual implementation. While the WHO resolution adopted in November 2025 provided formal recognition of the need for global attention to kidney health, the authors argue that such agreements often fail to produce results due to systemic opposition and a lack of political will.

How can diabetes control models improve kidney health?

The Lancet authors propose that kidney health initiatives mirror the operational framework of diabetes management. According to the paper, diabetes control has successfully moved from isolated clinical treatment to a systemic public health approach involving early screening, standardized care pathways, and integrated medication access.

By applying these lessons, the paper suggests that CKD can be managed through similar proactive measures. This includes shifting the focus from end-stage renal failure treatment, such as dialysis, toward early detection and prevention strategies that are already embedded in diabetes care protocols.

Why is the November 2025 WHO resolution facing implementation hurdles?

Implementation of the November 2025 resolution is hindered by what the Lancet describes as opposition, inertia, and indifference. The paper notes that CKD has suffered from decades of neglect compared to other major health crises.

This neglect often stems from the “silent” nature of kidney disease, which frequently progresses without obvious symptoms until the advanced stages. The authors argue that this lack of visibility leads to a lack of urgency in policy circles, making the resolution’s promises difficult to fulfill without a concrete operational roadmap.

What is the role of the non-communicable disease agenda?

The Lancet guidance calls for the full integration of kidney health into the broader non-communicable disease (NCD) agenda. NCDs, which include cardiovascular diseases, cancers, and chronic respiratory diseases, already have established global monitoring and funding frameworks.

Integrating CKD into this agenda allows kidney health to benefit from existing infrastructure rather than attempting to build a standalone system. The authors suggest that because CKD is often a complication of other NCDs, such as hypertension and diabetes, a combined approach is more efficient for healthcare delivery.

Efforts to implement and operationalise these kinds of agreements are often met with opposition, inertia, and indifference.

The move toward integration represents a shift in strategy from the November 2025 resolution’s broad recognition of the problem to the June 13, 2026, paper’s focus on practical execution. While the WHO resolution established the mandate, the Lancet paper provides the tactical guidance necessary to move kidney health from a peripheral concern to a central component of global health policy.

Failure to integrate these services could result in the November 2025 resolution remaining a symbolic gesture. The Lancet suggests that without a shift toward the NCD model, the gap between policy intent and patient outcomes in kidney care will likely persist.